K E N R E S E A R C H USA Patient Registry Software Market Size, Growth and Forecast: Ken Research Examines the Cloud Evidence Shift Market Research Report November 19, 2026 www kenresearch com Table of Contents 1. Market Revenue Could More Than Double as Registry Platforms Become Evidence Infrastructure 2. Widespread EHR Adoption Creates the Foundation for Automated Patient Registries 3. Cloud SaaS and API Integration Are Redefining Software Value 4. How Patient Registry Software Market Segmentation Shapes Commercial Demand 5. Disease Registries Lead Established Demand 6. Deployment and Application Requirements Vary by Buyer 7. Real - World Evidence and Regulatory Expectations Strengthen Registry Demand 8. Competitive Advantage Depends on Integration Depth and Clinical Specialization 9. Regional Concentration Favors Enterprise Partnerships and Multi - Site Deployment 10. Implementation Costs and Data Governance Remain Critical Growth Constraints 11. Frequently Asked Questions 12. Q 1. What is the USA patient registry software market size and forecast to 2031? 13. Q 2. What is driving growth in the U S patient registry software market ? 14. Q 3. Who are the major patient registry software companies in the United States ? USA Patient Registry Software Market Size, Growth and Forecast: Ken Research Examines the Cloud Evidence Shift The USA patient registry software market is entering a new phase as healthcare organizations move beyond basic patient data collection toward connected platforms for clinical outcomes , quality measurement and real - world evidence According to Ken Research , the market generated USD 820 million in revenue in 2025 and is projected to reach USD 1,663 million by 2031 , growing at a 12.5% compound annual growth rate ( CAGR ) during 2026 - 2031 Healthcare providers , pharmaceutical sponsors and medical societies increasingly need longitudinal data that supports clinical decisions , regulatory submissions and measurable improvements in care quality The commercial opportunity is therefore moving from standalone registry databases toward interoperable cloud software , automated data abstraction and managed evidence services Market Revenue Could More Than Double as Registry Platforms Become Evidence Infrastructure Ken Research estimates that U S patient registry software revenue increased from USD 455 million in 2020 to USD 820 million in 2025 Its forecast projects USD 921 million in 2026 , USD 1,476 million in 2030 and USD 1,663 million in 2031 The market specifically includes software licenses , cloud subscriptions , interoperability , analytics , support and managed services directly attributable to patient registries General electronic health records ( EHRs ), clinical trial management systems and broader healthcare analytics platforms are excluded unless their revenue is linked directly to registry functions Ken Research forecasts active paid registry deployments increasing from 5,900 in 2025 to 10,300 in 2031 , approximately 74.6% growth Revenue is projected to increase by approximately 102.8% over the same period Calculated from those forecasts , the difference indicates that annual market revenue per active deployment rises by approximately 16% , from about USD 139,000 to USD 161,000 This suggests that additional spending on interoperability , analytics , automation and managed services will be commercially important alongside new customer acquisition Widespread EHR Adoption Creates the Foundation for Automated Patient Registries Patient registry systems depend on reliable clinical information collected across treatment settings and over time Historically , manual abstraction , inconsistent record structures and disconnected hospital systems created significant operating burdens According to the Office of the National Coordinator for Health Information Technology ' s National Trends in Hospital and Physician Adoption of Electronic Health Records , 91% of U S office - based physicians and more than 99% of non - federal acute - care hospitals had adopted certified EHRs in 2024 Vendors can increasingly integrate with existing clinical systems rather than rely entirely on separate data - entry workflows However , the availability of an EHR does not automatically guarantee complete , standardized or research - ready registry data The adjacent United States Electronic Health Records Market provides additional context for understanding how healthcare software infrastructure , cloud migration and interoperability investment influence registry adoption For registry buyers , the critical question is whether a platform can reliably extract , validate , normalize and update patient information across multiple facilities without creating excessive clinical administration costs Cloud SaaS and API Integration Are Redefining Software Value Ken Research estimates that Cloud SaaS accounted for 68% of U S registry software revenue in 2025 , with its share forecast to reach 84% by 2031 The same analysis reports that FHIR / API - enabled deployments represented 63% of active implementations in 2025 and are forecast to reach 86% by 2031 These indicators point toward growing demand for platforms that connect clinical records , patient - reported outcomes , research workflows and reporting systems Cloud - based architectures support coordinated registry operations across geographically dispersed care networks API integration can reduce repetitive abstraction and facilitate longitudinal updates , while automated validation tools can improve data completeness and consistency Vendors must address patient identity matching , consent management , access controls , data provenance and differences between clinical coding systems For buyers evaluating enterprise implementations , these capabilities can be more consequential than headline functionality How Patient Registry Software Market Segmentation Shapes Commercial Demand Ken Research segments the U S market across solution type , deployment model , end user , application , technology , pricing model and geography Registry purchasing requirements differ substantially between hospitals , medical societies , pharmaceutical sponsors and public agencies Disease Registries Lead Established Demand Disease Registries represent the largest solution - type revenue pool according to Ken Research Oncology , cardiovascular conditions , metabolic disorders and rare diseases often require structured follow - up , standardized outcomes and specialist data governance Other solution categories include Product Registries , Health Service Registries and Population Health Registries Product registries are particularly relevant to post - market surveillance , where manufacturers require long - term safety and performance evidence Deployment and Application Requirements Vary by Buyer Deployment models include Cloud SaaS , Private Cloud , On - Premise and Hybrid Deployment Cloud SaaS is identified as the fastest - growing delivery model , while private and hybrid configurations remain relevant to organizations with specialized security and operational requirements The report distinguishes Hospitals and Health Systems , Life Sciences Sponsors , Specialty Societies and Qualified Clinical Data Registries ( QCDRs ), and Government and Public Health Agencies as end - user categories Applications include Post - Market Surveillance , Clinical Outcomes Research , Quality Measurement and Reporting , and Rare Disease Natural History Technology categories encompass EHR and API - Integrated Platforms , Standalone Web Platforms , Mobile and ePRO - Enabled Registries , and AI - Assisted Data Abstraction Related research on the USA Clinical Trial Management System Market provides additional perspective on software procurement within pharmaceutical research and clinical - study operations , although trial management and patient registry platforms serve distinct functions Pricing models range from Annual Subscription and Per - Registry License to Per - Patient Pricing and Managed Service Contract Commercial evaluation should therefore consider implementation workload , ongoing abstraction requirements and service responsibilities , not simply license fees The full report provides segmentation across these solution , deployment , end - user , application , technology , pricing and geographic categories Real-World Evidence and Regulatory Expectations Strengthen Registry Demand Regulatory acceptance of real - world evidence is expanding the strategic relevance of validated patient registries Longitudinal information can support safety surveillance , disease characterization , treatment - outcome evaluation and selected regulatory research applications when the underlying data and methodology are appropriate The U S Food and Drug Administration ' s July 2024 guidance on assessing EHR and medical claims data for regulatory decision - making describes considerations for using routinely collected information in clinical studies supporting drug and biological product decisions Such guidance does not make every registry dataset automatically acceptable as regulatory evidence Sponsors must evaluate source reliability , data relevance , completeness , traceability and whether the information can answer the intended research question This creates a differentiated commercial opportunity for vendors that combine registry software with clinical governance , data - quality management , auditability and research services Registry software value increasingly depends on interoperable clinical data , reliable longitudinal evidence and scalable cloud - based operations To follow related healthcare technology analysis , Add Ken Research as a Preferred Source on Google For life sciences sponsors , data lineage , protocol - specific configuration , patient follow - up and the ability to generate reproducible evidence become important considerations when selecting registry technology partners Competitive Advantage Depends on Integration Depth and Clinical Specialization The USA patient registry software market includes enterprise healthcare technology providers , specialist registry developers and managed - service organizations Ken Research identifies 148 market participants and describes an enterprise tier with moderate concentration alongside a fragmented specialist provider landscape Named competitors include IQVIA , Medidata Solutions , Oracle Life Sciences , Health Catalyst and Fivos Health The competitive landscape also includes FIGmd ( MRO ), ArborMetrix , Veeva Systems , OpenClinica and Dacima Software These companies address different operational needs , from pharmaceutical evidence generation and clinical data capture to specialty registries , quality reporting and automated abstraction The competitive distinction is particularly important when comparing registry - specific solutions with the broader United States Healthcare Analytics Market Analytics capabilities support registry value , but broad healthcare analytics revenue should not be treated as patient registry software revenue For technology buyers , meaningful supplier evaluation should focus on demonstrated integrations , disease - specific experience , implementation references , security capabilities , data ownership arrangements and long - term support commitments Regional Concentration Favors Enterprise Partnerships and Multi-Site Deployment Ken Research estimates that the South and Southeast accounted for approximately 31% of U S patient registry software revenue in 2025 , supported by major health systems , research activity and healthcare technology operations across states including Texas , Florida , Georgia and North Carolina The report also segments the market geographically into Northeast , South , Midwest and West These regions differ in provider composition , research ecosystems and institutional purchasing relationships Large health networks can centralize procurement across multiple facilities , making interoperability , contract structure and enterprise governance essential to commercial execution Ken Research ' s country comparison also places the United States ahead of selected peers by 2025 market revenue The U S estimate of USD 820 million exceeds the United Kingdom ' s USD 153 million , although the report projects faster percentage growth in several smaller international markets Implementation Costs and Data Governance Remain Critical Growth Constraints Despite favorable revenue forecasts , registry software adoption faces practical obstacles Healthcare organizations must manage integration costs , inconsistent EHR data structures , cybersecurity obligations and limited technical resources Ken Research identifies procurement friction , hospital budget pressure , cybersecurity expenditure and EHR heterogeneity among the constraints incorporated into its market outlook Analysis of these barriers suggests three priorities for successful market participation : reusable interoperability connectors , clinically validated registry configurations and predictable implementation economics For healthcare organizations , the evaluation should extend beyond annual subscription pricing Total ownership costs may include onboarding , data migration , validation , maintenance , audit preparation , patient engagement and ongoing managed services The broader research portfolio available through Ken Research can help place registry software decisions within related healthcare IT investment categories However , adjacent market forecasts should remain separate from the narrower registry - specific revenue estimates Frequently Asked Questions Q1. What is the USA patient registry software market size and forecast to 2031? According to Ken Research , the USA patient registry software market was valued at USD 820 million in 2025 and is forecast to reach USD 1,663 million by 2031 , representing a 12.5% CAGR during 2026 - 2031 This includes registry - related software , cloud subscriptions , implementation , interoperability , analytics and managed operations , rather than the entire healthcare IT software industry Q2. What is driving growth in the U.S. patient registry software market? Growth is driven by cloud adoption , EHR interoperability , real - world evidence programs and demand for longitudinal clinical outcomes Ken Research projects Cloud SaaS revenue share increasing from 68% in 2025 to 84% by 2031 Healthcare providers and research sponsors are also seeking automated data collection , reliable quality reporting and improved evidence governance Q3. Who are the major patient registry software companies in the United States? Ken Research identifies IQVIA , Medidata Solutions , Oracle Life Sciences , Health Catalyst and Fivos Health among the major participants Other companies covered include FIGmd ( MRO ), ArborMetrix , Veeva Systems , OpenClinica and Dacima Software Vendor selection depends on the registry ' s clinical purpose , required integrations , research capabilities , deployment architecture and ongoing service needs As the market develops , profitable growth will depend less on adding isolated registry installations and more on enabling reliable evidence generation at scale Review the USA Patient Registry Software Market report to evaluate revenue forecasts through 2031 , solution and deployment segmentation , competitive benchmarking , pricing models and market - entry strategies Use its analysis to compare technology providers , prioritize customer segments and assess opportunities across clinical registries and real - world evidence services kenresearch com